| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |